Skip to main content
. 2022 Jul 1;12(3):e12113. doi: 10.1002/pul2.12113
Key objectives for future research—authors' proposals
  • To standardize the assessment and reporting of pulmonary vascular manifestations and sequelae of COVID‐19
  • To evaluate the potential of new imaging tools to detect subtle morphological abnormalities in the pulmonary vasculature, differentiate pulmonary thromboinflammatory disease from thromboembolic disease and quantify changes over time
  • To develop and validate artificial intelligence models for the identification of pulmonary vascular manifestations and sequelae of COVID‐19 and the prediction of treatment outcomes
  • To understand the mechanism and optimize the treatment of COVID‐19‐associated pulmonary thromboinflammatory disease
  • To assess the incidence of chronic thromboembolic pulmonary hypertension during long‐term follow‐up after COVID‐19